UBS analyst Karl Keirstead raised the firm’s price target on Oracle (ORCL) to $210 from $200 and keeps a Buy rating on the shares. A continued solid tone on the upcoming Q3 and Q4 leaves the core growth acceleration thesis intact even as shares cool off likely due to the lack of material Q2 upside, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ORCL:
- Oracle price target raised to $150 from $140 at DA Davidson
- Oracle price target raised to $175 from $155 at Stifel
- Oracle price target raised to $200 from $190 at Evercore ISI
- Oracle price target raised to $210 from $185 at Mizuho
- Oracle price target raised to $205 from $173 at BMO Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
